Physician profile
Karin Taylor
NPI 1366768459
$1,335.98
in general payments reported to CMS, 2019-2025
19 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $31.51 · 2021: $43.32 · 2022: $197 · 2023: $472 · 2024: $336 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $934.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $934.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $270.66 | 2022-2025 | Botox |
| Janssen Biotech, INC. | $208.12 | 2022-2024 | Tremfya, Simponi Aria |
| Amgen INC. | $205.80 | 2023-2024 | Otezla, Enbrel, Evenity |
| Avanir Pharmaceuticals, INC. | $101.14 | 2019-2022 | |
| Boston Scientific Corporation | $96.64 | 2021-2024 | Spaceoar Vue System - 10ml |
| Teleflex LLC | $76.07 | 2024 | Urolift |
| Organon LLC | $64.38 | 2023-2024 | Renflexis, Hadlima |
| Ucb, INC. | $56.01 | 2023-2025 | Cimzia, Bimzelx |
| Allergan, INC. | $54.49 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $37.08 | 2023 | Iovera, Zilretta, Exparel |
| Regeneron Healthcare Solutions, INC. | $27.68 | 2025 | Libtayo |
| Medtronic, INC. | $25.22 | 2023 | Interstim |
| Shire North American Group INC | $19.90 | 2019 | |
| Integra Lifesciences Corporation | $17.40 | 2020 | |
| Janssen Pharmaceuticals, INC | $16.66 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $16.44 | 2022 | |
| Depuy Synthes Sales INC. | $14.67 | 2025 | Orthovisc |
| Aroa Biosurgery Incorporated | $14.11 | 2020 | |
| Lilly USA, LLC | $13.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karin Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.